Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment

Epistaxis management on COVID‐19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bathula, Samba Siva R., Patrick, Tyler, Srikantha, Luxman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404437/
https://www.ncbi.nlm.nih.gov/pubmed/32837722
http://dx.doi.org/10.1002/ccr3.3137
_version_ 1783567137048100864
author Bathula, Samba Siva R.
Patrick, Tyler
Srikantha, Luxman
author_facet Bathula, Samba Siva R.
Patrick, Tyler
Srikantha, Luxman
author_sort Bathula, Samba Siva R.
collection PubMed
description Epistaxis management on COVID‐19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID‐19 transmission to surrounding healthcare workers.
format Online
Article
Text
id pubmed-7404437
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74044372020-08-05 Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment Bathula, Samba Siva R. Patrick, Tyler Srikantha, Luxman Clin Case Rep Case Reports Epistaxis management on COVID‐19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID‐19 transmission to surrounding healthcare workers. John Wiley and Sons Inc. 2020-07-21 /pmc/articles/PMC7404437/ /pubmed/32837722 http://dx.doi.org/10.1002/ccr3.3137 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Bathula, Samba Siva R.
Patrick, Tyler
Srikantha, Luxman
Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment
title Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment
title_full Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment
title_fullStr Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment
title_full_unstemmed Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment
title_short Epistaxis management on COVID‐19–positive patients: Our early case experience and treatment
title_sort epistaxis management on covid‐19–positive patients: our early case experience and treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404437/
https://www.ncbi.nlm.nih.gov/pubmed/32837722
http://dx.doi.org/10.1002/ccr3.3137
work_keys_str_mv AT bathulasambasivar epistaxismanagementoncovid19positivepatientsourearlycaseexperienceandtreatment
AT patricktyler epistaxismanagementoncovid19positivepatientsourearlycaseexperienceandtreatment
AT srikanthaluxman epistaxismanagementoncovid19positivepatientsourearlycaseexperienceandtreatment

Ejemplares similares